News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Esperion Therapeutics, Inc. (ESPR) To Present At Jefferies and Co. 2014 Global Healthcare Conference



5/30/2014 7:21:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Esperion Therapeutics Inc. (NASDAQ: ESPR), a clinical stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, today announced the Company will present at the Jefferies 2014 Global Healthcare Conference in New York City, N.Y. Tim M. Mayleben, president and chief executive officer, will provide an update on the company on Thursday, June 5 at 2:30 p.m. Eastern Time.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES